|
1.
|
|
12 p, 780.3 KB |
Observational cohort study of rilpivirine (RPV) utilization in Europe
/
Cozzi-Lepri, Alessandro (Centre for Clinical Research. Epidemiology. Modelling and Evaluation (CREME). Institute for Global Health. University College London) ;
Peters, Lars (CHIP. Rigshospitalet. University of Copenhagen) ;
Pelchen-Matthews, Annegret (Centre for Clinical Research. Epidemiology. Modelling and Evaluation (CREME). Institute for Global Health. University College London) ;
Neesgaard, Bastian (CHIP. Rigshospitalet. University of Copenhagen (Belgium)) ;
De Wit, Stéphane (Université Libre de Bruxelles, Department of Infectious Diseases) ;
Johansen, Isik Somuncu (Odense University Hospital (Dinamarca)) ;
Edwards, Simon (Mortimer Market Centre, Department of HIV (London)) ;
Stephan, Christoph (Infectious Diseases Unit. Goethe-University Hospital) ;
Adamis, Georgios (General Hospital of Athens G. Gennimatas (Greece)) ;
Staub, Therese (Centre Hospitalier de Luxembourg, Service des Maladies Infectieuses (Luxembourg)) ;
Zagalo, Alexandra (Santa Maria University Hospital, Department of Infectious Diseases (Lisbon, Portugal)) ;
Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ;
Elbirt, Daniel (Allergy. Immunology and HIV Unit | Kaplan. Medical Center) ;
Kusejko, Katharina (University Hospital Zürich (Switzerland)) ;
Brännström, Johanna (Department of Infectious Diseases. Venhälsan Södersjukhuset) ;
Paduta, Dzmitry (Gomel Regional Centre for Hygiene) ;
Trofimova, Tatyana (Novgorod Centre for AIDS Prevention and Control) ;
Szlavik, Janos (South-Pest Hospital Centre-National Institute for Infectiology and Haematology) ;
Zilmer, Kai (West-Tallinn Central Hospital, Infectious Diseases Clinic (Talinn, Estonia)) ;
Losso, Marcello (Hospital J.M. Ramos Mejia (Buenos Aires)) ;
Van Eygen, Veerle (Janssen Research & Development) ;
Pai, Helen (Janssen Research & Development) ;
Lundgren, Jens (CHIP. Rigshospitalet. University of Copenhagen) ;
Mocroft, Amanda (Rigshospitalet. University of Copenhagen (Denmark)) ;
Harxhi, Arjan (Medical University of Tirana (Albania)) ;
Losso, Marcelo Horacio (Hospital General de Agudos JM Ramos Mejía (Buenos Aires)) ;
Kundro, Mariana (Hospital General de Agudos JM Ramos Mejía (Buenos Aires)) ;
Schmied, Brigitte (Institute of Science and Technology Austria (ISTA)) ;
Karpov, Igor Alexandrovich (Belarusian State Medical University (Minsk)) ;
Vassilenko, Anna (Belarusian State Medical University (Minsk)) ;
Paduto, Dmitriy (Regional AIDS Centre (Svetlogorsk, Bèlgica)) ;
Mitsura, Victor (Gomel State Medical University) ;
Clumeck, Nathan (University Hospital Brussels) ;
De Wit, Stéphane A. (Université Libre de Bruxelles) ;
Delforge, Marc D. (Université Libre de Bruxelles) ;
Hadziosmanovic, Vesnadarjan (Clinical Center University of Sarajevo) ;
Begovac, Josip (University of Zagreb) ;
Machala, Ladislav (Charles University in Prague) ;
Jilich, David (Charles University in Prague) ;
Gerstoft, Jan (IT University of Copenhagen) ;
Torp-Pedersen, Christian (Aalborg Universitet) ;
Sedlacek, Dalibor (Fakultní nemocnice Plzeň) ;
Kronborg, Gitte (University of Copenhagen) ;
Benfield, Thomas (Copenhagen University Hospital Hvidovre) ;
Johansen, IS (Odense University Hospital (Dinamarca)) ;
Ostergaard, Leif (Aarhus University) ;
Wiese, Lothar (Roskilde University) ;
Friis-Moller, Nina (Zealand University Hospital) ;
Nielsen, Lars Norregård (Hillerod Hospital (Hillerod, Dinamarca)) ;
Zilmer, Kai (Kaunas University of Technology) ;
Smidt, Jelena (Kohtla - Jarve Jarve Gümnaasium) ;
Aho, Inka (Helsinki University Central Hospital) ;
Viard, Jean-Paul (Université Paris Cité) ;
Girard, Pierre-Marie (University of Paris-Est) ;
Pradier, Christian (Centre Hospitalier Universitaire de Nice) ;
Fontas, Eric (Centre Hospitalier Universitaire de Nice) ;
Duvivier, Claudine (Hôpital Universitaire Necker) ;
Rockstroh, Jurgen (Universitätsklinikum Bonn) ;
Degen, Olaf (University Medical Center Hamburg) ;
Hoffmann, C. (IPM Study Center) ;
Stellbrink, H.J. (IPM Study Center) ;
Stefan, C. (JW Goethe University Hospital (Frankfurt)) ;
Bogner, Johannes (University Hospital München) ;
Fätkenheuer, Gerd (University of Cologne) ;
Chkhartishvili, N. (Infectious Diseases, AIDS and Clinical Immunology Research Center) ;
Sambatakou, Helen (Hippokration General Hospital (Athens)) ;
Paissios, N. (Athens General Hospital "G Gennimatas") ;
Uzdaviniene, V. (Vilnius University Hospital Santariskiu Clinics) ;
Staub, T. (Centre Hospitalier de Luxembourg) ;
Dragas, S. ;
Reiss, P. (University of Amsterdam) ;
Trajanovska, J. (University Clinic for Infectious Diseases & Febrile Conditions (Skopje)) ;
Reikvam, Dag Henrik (Oslo University Hospital (Oslo, Noruega)) ;
Maeland, A. (Oslo University Hospital (Oslo, Noruega)) ;
Bruun, Johan (University Hospital of North Norway) ;
Knysz, B. (WWF Poland) ;
Szetela, Bartosz (Nicolaus Copernicus University) ;
Inglot, Malgorzata (Wroclaw Medical University) ;
Bakowska, E. (Hospital For Infectious Diseases (Warsaw)) ;
Flisiak, Robert (Medical University of Bialystok) ;
Grzeszczuk, Anna (Medical University of Bialystok) ;
Parczewski, Miłosz (Pomeranian Medical University in Szczecin) ;
Maciejewska, Katarzyna (Pomeranian Medical University in Szczecin) ;
Aksak-Was, Bogusz (Pomeranian Medical University in Szczecin) ;
Beniowski, Marek (Medical University of Silesia in Katowice) ;
Mularska, Elżbieta ;
Jablonowska, Elżbieta (University of Lodz) ;
Kamerys, J. (Poznan University of Medical Sciences) ;
Wojcik, K. (University of Lodz) ;
Mozer-Lisewska, Iwona (Uniwersytet Medyczny im.Karola Marcinkowskiego w Poznaniu) ;
Rozplochowski, Błażej (Poznan University of Medical Sciences) ;
Zagalo, A. (Hospital Santa Maria (Lisboa, Portugal)) ;
Radoi, Roxana (Clinical Hospital Of Infectious Diseases "Dr. Victor Babes") ;
Oprea, Cris (Joint Institute for Nuclear Research) ;
Yakovlev, A. (Saint Petersburg State University) ;
Trofimora, T. (Novgorod Centre for AIDS (Novgorod)) ;
Khromova, I. (Tomsk Regional Center of AIDS and infectious diseases prophylaxis and control" (RCAIDPC)) ;
Kuzovatova, Elena (Blokhina Scientific Research Institute of Epidemiology and Microbiology of Nizhny Novgorod) ;
Borodulina, Elena (Samara State Medical University) ;
Vdoushkina, Elena (Samara State Medical University) ;
Ranin, Jovan (Klinički centar Srbije) ;
Tomazic, J. (Ljubljana University Medical Centre) ;
Miro, Josep M. (Instituto de Salud Carlos III) ;
Laguno, Montse (Hospital Clínic i Provincial de Barcelona) ;
Martinez, E. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Garcia, F. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Blanco, J.L. (Hospital Clínic i Provincial de Barcelona) ;
Martinez-Rebollar, María (Hospital Clínic i Provincial de Barcelona) ;
Mallolas Masferrer, Josep (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Callau, Pilar (Universitat de Barcelona) ;
Rojas, J. (Hospital Clínic i Provincial de Barcelona) ;
Moreno, Santiago (Pontifical Catholic University of Argentina) ;
del Campo, Santos (Hospital Universitario Ramón y Cajal (Madrid)) ;
Jou, A. (IrsiCaixa Institute for AIDS Research) ;
Paredes, Roger (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Puig, Jordi (Universitat Autònoma de Barcelona) ;
Llibre, Josep M.. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Santos, J.R. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Domingo, Pere (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Gutierrez, M. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Mateo, G.M. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Sambeat, A. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Laporte, J.M. (Hospital Universitario de Alava) ;
Svedhem, V. (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Thalme, Anders (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Sonnerborg, A. (Karolinska University Hospital) ;
Flamholc, L. (Skåne University Hospital (Suècia)) ;
Kusejko, Katharina (University of Zurich) ;
Weber, R. (Universitäts-Herzzentrum Freiburg - Bad Krozingen) ;
Calmy, Alexandra (University of Geneva) ;
Furrer, Hansjakob (Inselspital, Universitätsspital Bern) ;
Battegay, Manuel (University of Basel) ;
Schmid, P. (Cantonal Hospital of Schwyz) ;
Kuznetsova, A. (Kyiv National Economic University) ;
Mikhalik, Julia (Crimean Republican AIDS centre) ;
Sluzhynska, M. (International HIV/AIDS Alliance in Ukraine) ;
Milinkovic, Ana (Imperial College London) ;
Johnson, A.M. (Mortimer Market Centre) ;
Simons, Edwards (Mortimer Market Centre) ;
Edwards, S. (Brookhaven National Laboratory) ;
Phillips, A.M. (Royal Free and University College Medical School) ;
Johnson, M.A. (Royal Free and University College Medical School) ;
Mocroft, A. (Royal Free and University College Medical School) ;
Orkin, Chloe (Queen Mary, University of London) ;
Winston, Alan (Imperial College London) ;
Clarke, A. (University of Sussex) ;
Leen, Clifford (The University of Edinburgh)
Introduction: Data on safety and effectiveness of RPV from the real-world setting as well as comparisons with other NNRTIs such as efavirenz (EFV) remain scarce. Methods: Participants of EuroSIDA were included if they had started a RPV- or an EFV-containing regimen over November 2011-December 2017. [...]
2022 -  10.1186/s12981-022-00457-0
AIDS Research and Therapy, Vol. 19 Núm. 1 (december 2022) , p. 38
|
|
|
2.
|
|
11 p, 844.8 KB |
Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis
/
Calvi, Alberto (University College London) ;
Clarke, Margareta A. (Hospital Universitari Vall d'Hebron) ;
Prados Carrasco, Ferran (University College London) ;
Chard, Declan (University College London) ;
Ciccarelli, Olga (University College London) ;
Alberich, Manel (Hospital Universitari Vall d'Hebron) ;
Pareto, Deborah (Hospital Universitari Vall d'Hebron) ;
Rodríguez Barranco, Marta (Hospital Universitari Vall d'Hebron) ;
Sastre-Garriga, Jaume (Hospital Universitari Vall d'Hebron) ;
Tur, Carmen (Hospital Universitari Vall d'Hebron) ;
Rovira, Alex (Hospital Universitari Vall d'Hebron) ;
Barkhof, Frederik (University College London) ;
Universitat Autònoma de Barcelona
Magnetic resonance imaging (MRI) markers for chronic active lesions in MS include slowly expanding lesions (SELs) and paramagnetic rim lesions (PRLs). To identify the relationship between SELs and PRLs in MS, and their association with disability. [...]
2022 - 10.1177/13524585221141964
Multiple sclerosis, Vol. 29 (december 2022) , p. 352-362
|
|
|
3.
|
|
9 p, 1.1 MB |
Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis
/
Meaton, Isobel (University of Nottingham) ;
Altokhis, Amjad (University of Nottingham) ;
Allen, Christopher Martin (University of Nottingham) ;
Clarke, Margareta A. (Vanderbilt University) ;
Sinnecker, Timm (University Basel) ;
Meier, Dominik (University Basel) ;
Enzinger, Christian (Medical University of Graz) ;
Calabrese, Massimiliano (University of Verona) ;
De Stefano, Nicola (University of Siena) ;
Pitiot, Alain (Laboratory of Image and Data Analysis (Regne Unit)) ;
Giorgio, Antonio (University of Siena) ;
Schoonheim, Menno M. (Universiteit Amsterdam) ;
Paul, Friedemann (Charité - Universitätsmedizin Berlin) ;
Pawlak, Mikolaj A. (Poznan University of Medical Sciences) ;
Schmidt, Reinhold (Medical University of Graz) ;
Granziera, Cristina (University of Basel) ;
Kappos, Ludwig (University of Basel) ;
Montalban, Xavier (Hospital Universitari Vall d'Hebron) ;
Rovira, Alex (Hospital Universitari Vall d'Hebron) ;
Wuerfel, Jens (Charité - Universitätsmedizin Berlin) ;
Evangelou, Nikos (University of Nottingham) ;
Universitat Autònoma de Barcelona
White matter lesions (WMLs) on brain magnetic resonance imaging (MRI) in multiple sclerosis (MS) may contribute to misdiagnosis. In chronic active lesions, peripheral iron-laden macrophages appear as paramagnetic rim lesions (PRLs). [...]
2022 - 10.1177/13524585221118677
Multiple sclerosis, Vol. 28 (august 2022) , p. 2212-2220
|
|
|
4.
|
|
9 p, 1.6 MB |
Differential miRNAs in acute spontaneous coronary artery dissection : Pathophysiological insights from a potential biomarker
/
Lozano-Prieto, Marta (Hospital Universitario de la Princesa (Madrid)) ;
Adlam, David (NIHR Leicester Biomedical Research Centre) ;
García-Guimaraes, Marcos (Hospital del Mar (Barcelona, Catalunya)) ;
Sanz-García, Ancor (Hospital Universitario de la Princesa (Madrid)) ;
Vera-Tomé, Paula (Hospital Universitario de la Princesa (Madrid)) ;
Rivero, Fernando (Hospital Universitario de la Princesa (Madrid)) ;
Cuesta, Javier (Hospital Universitario de la Princesa (Madrid)) ;
Bastante, Teresa (Hospital Universitario de la Princesa (Madrid)) ;
Baranowska-Clarke, Anna A. (NIHR Leicester Biomedical Research Centre) ;
Vara, Alicia (Hospital Universitario de la Princesa (Madrid)) ;
Martin-Gayo, Enrique (Hospital Universitario de la Princesa (Madrid)) ;
Vicente-Manzanares, Miguel (Instituto de Biología Molecular y Celular del Cáncer USAL-CSIC) ;
Martín, Pilar (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Samani, Nilesh J. (NIHR Leicester Biomedical Research Centre) ;
Sánchez-Madrid, Francisco (Hospital Universitario de la Princesa (Madrid)) ;
Alfonso, Fernando (NIHR Leicester Biomedical Research Centre) ;
de la Fuente, Hortensia (Hospital Universitario de la Princesa (Madrid)) ;
Universitat Autònoma de Barcelona
Spontaneous Coronary Artery Dissection (SCAD) is an important cause of acute coronary syndromes, particularly in young to middle-aged women. Differentiating acute SCAD from coronary atherothrombosis remains a major clinical challenge. [...]
2021 - 10.1016/j.ebiom.2021.103338
EBioMedicine, Vol. 66 (april 2021)
|
|
|
5.
|
|
11 p, 1.6 MB |
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
/
Eron, J. J. (University of North Carolina School of Medicine) ;
Orkin, C. (Department of HIV Medicine. Royal Free London NHS Foundation Trust) ;
Cunningham, D. (Pueblo Family Physicians) ;
Pulido, F. (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Post, F. (King's College Hospital NHS Foundation Trust) ;
De Wit, Stéphane (Université Libre de Bruxelles) ;
Lathouwers, E. (Janssen Pharmaceutica NV) ;
Hufkens, V. (Janssen Pharmaceutica NV) ;
Jezorwski, J. (Janssen Research & Development) ;
Petrovic, R. (Janssen Pharmaceutica NV) ;
Brown, K. (Janssen Pharmaceutica NV) ;
Van Landuyt, E. (Janssen Pharmaceutica NV) ;
Opsomer, M. (Janssen Pharmaceutica NV) ;
De Wit, Stéphane (Université Libre de Bruxelles) ;
Florence, E. (Institute of Tropical Medicine) ;
Moutschen, M. (Liège University Hospital (Bèlgica)) ;
Van Wijngaerden, E. (University Hospitals Leuven (Bèlgica)) ;
Vandekerckhove, L. (Ghent University Hospital. (Bèlgica)) ;
Vandercam, B. (AIDS Reference center. Cliniques Universitaires Saint-Luc) ;
Brunetta, J. (Maple Leaf Medical Clinic) ;
Conway, B. (Vancouver Infectious Diseases Center) ;
Klein, M. (Division of Infectious Diseases. Faculty of Medicine. McGill University Health Centre) ;
Murphy, D. (Institut national de santé publique du Québec) ;
Rachlis, A. (Sunnybrook Health Sciences Centre) ;
Shafran, S. (Department of Medicine. University of Alberta) ;
Walmsley, S. (University Health Network) ;
Ajana, F. (Infectious Diseases Department. Tourcoing Hospital) ;
Cotte, L. (Hospices Civils de Lyon. Hôpital de la Croix-Rousse) ;
Girardy, P. M. (University Pierre & Marie Curie) ;
Katlama, C. (HIV Clinical Research Unit) ;
Molina, J. M. (Department of Infectious Diseases. St-Louis Hospital APHP. University of Paris Diderot) ;
Poizot-Martin, I. (Clinical Immuno-Hematology Department. Aix-Marseille University. Sainte-Marguerite University Hospital and Inserm U912) ;
Raffi, F. (CHU Hôtel Dieu) ;
Rey, D. (Le Trait d'Union. HIV-Infection Care Center. Hôpitaux Universitaires de Strasbourg) ;
Reynes, J. (University Hospital of Montpellier (França)) ;
Teicher, E. (Infectious Diseases Department. APHP. Hôpital Bicêtre) ;
Yazdanpanah, Y. ;
Gasiorowski, J. (Independent Laboratory for Monitoring Infections among Drug Users at the Department of Infectious Diseases. Liver Disease and Acquired Immune Deficiencies. Wroclaw Medical University) ;
Halota, W. (Department of Infectious Diseases and Hepatology. Nicolaus Copernicus University) ;
Horban, A. (Medical University of Warsaw. Department for Adult's Infectious Diseases) ;
Piekarska, A. (Department of Infectious Diseases and Hepatology. Medical University of Lodz) ;
Witor, A. (Regional Hospital. Out-Patient's Clinic for Immune Deficiency) ;
Arribas, Jose (Instituto de Investigación Sanitaria del Hospital Universitario La Paz) ;
Perez-Valero, I. (Hospital Universitario La Paz (Madrid)) ;
Berenguer, Juan (Hospital General Universitario Gregorio Marañón) ;
Casado, José A. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Gatell, J. M. (Infectious Diseases Department. HCB) ;
Gutiérrez, Félix (Hospital General Universitario de Elche) ;
Galindo, María José (Hospital Clínic Universitari (València)) ;
Gutiérrez Macià, Mª Del Mar (Institut d'Investigació Biomèdica Sant Pau) ;
Iribarren, J. A. (Hospital Universitario de Donostia (Sant Sebastià, País Basc)) ;
Knobel Freud, Hernando (Hospital del Mar (Barcelona, Catalunya)) ;
Negredo Puigmal, Eugènia. (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Pineda, J. A. (Hospital Universitario Virgen de Valme (Sevilla, Andalusia)) ;
Podzamczer, Daniel (Institut d'Investigació Biomèdica de Bellvitge) ;
Sogorb, J. P. (Hospital Universitario 12 de Octubre (Madrid)) ;
Pulido, F. (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Ricart, C. (Department of Microbiology. School of Medicine. University of Valencia) ;
Rivero Román, Antonio (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Santos Gil, I. (Hospital Universitario de la Princesa (Madrid)) ;
Blaxhult, A. (Department of Infectious Diseases. Venhälsan. Södersjukhuset) ;
Flamholc, L. (Skåne University Hospital (Suècia)) ;
Gisslèn, M. (Department of Infectious Diseases. University of Gothenburg) ;
Thalme, A. (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Fehr, J. (University Hospital Zurich (Suïssa)) ;
Rauch, A. (Bern University Hospital) ;
Stoeckle, M. (University Hospital Basel (Basilea, Suïssa)) ;
Clarke, A. (Claude Nicol Centre. Royal Sussex County Hospital. Brighton and Sussex University Hospitals NHS Trust) ;
Gazzard, B. G. (St. Stephen's Centre. Department of HIV/Genito-Urinary Medicine. Chelsea and Westminster Hospital) ;
Johnson, M. A. (Queen Mary University) ;
Orkin, C. (Department of HIV Medicine. Royal Free London NHS Foundation Trust) ;
Post, F. (King's College Hospital NHS Foundation Trust) ;
Ustianowski, Andrew (Regional Infectious Diseases Unit. North Manchester General Hospital) ;
Waters, L. (University College London Hospital) ;
Bailey, J. (Department of Medicine. Johns Hopkins University School of Medicine) ;
Benson, P. (Be Well Medical) ;
Bhatti, L. (AIDS Healthcare Foundation) ;
Brar, I. (Henry Ford Hospital) ;
Bredeek, U. F. (Metropolis Medical PC) ;
Brinson, C. (Central Texas Clinical Research) ;
Crofoot, G. (The Crofoot Research Center) ;
Cunningham, D. (Pueblo Family Physicians) ;
DeJesus, E. (Pueblo Family Physicians) ;
Dietz, C. (Orlando Immunology Center) ;
Dretler, R. (HIV Medicine. Kansas City Free Health Clinic) ;
Eron, J. (Infectious Disease Specialists of Atlanta) ;
Felizarta, F. (Private Practice) ;
Fichtenbaum, C. (University of Cincinnati College of Medicine) ;
Gallant, J. (Southwest CARE Center) ;
Gathe, J. (Therapeutic Concepts) ;
Hagins, D. (Georgia Department of Public Health. Chatham Care Center) ;
Henn, S. (Whitman-Walker Health) ;
Henry, W. K. (Department of Medicine. University of Minnesota Washington University School of Medicine) ;
Huhn, G. (Ruth M. Rothstein CORE Center) ;
Jain, M. (Department of Internal Medicine. University of Texas Southwestern Medical Center) ;
Lucasti, C. (South Jersey Infectious Disease) ;
Martorell, C. (Infectious Disease and The Research Institute) ;
McDonald, C. (Tarrant County Infectious Disease Associates) ;
Mills, A. (Southern California Men's Medical Group) ;
Morales-Ramirez, J. (Clinical Research Puerto Rico Inc.) ;
Mounzer, K. (Philadelphia FIGHT) ;
Nahass, R. (ID Care) ;
Olivet, H. (Community Research Initiative of New England) ;
Osiyemi, O. (Triple O Research Institute PA) ;
Prelutsky, D. (Department of Internal Medicine. Washington University School of Medicine) ;
Ramgopal, M. (Midway Immunology Center. Fort Pierce) ;
Rashbaum, B. (Capital Medical Associates) ;
Richmond, G. (Broward General Medical Center) ;
Ruane, P. (Ruane Clinical Research Group) ;
Scarsella, A. (Pacific Oaks Medical Group) ;
Scribner, A. (DCOL Center for Clinical Research) ;
Shalit, P. (Peter Shalit MD and Associates) ;
Shamblaw, D. (La Playa Medical Group) ;
Slim, J. (Department of Infectious Diseases. Seton Hall University) ;
Tashima, K. (The Miriam Hospital. Warren Alpert Medical School of Brown University) ;
Voskuhl, G. (AIDS Arms. Inc.) ;
Ward, D. (Dupont Circle Physicians Group) ;
Wilkin, A. (Wake Forest School of Medicine) ;
de Vente, J. (Living Hope Foundation) ;
Universitat Autònoma de Barcelona
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg was investigated through 96 weeks in EMERALD (NCT02269917). Virologically-suppressed, HIV-1-positive treatment-experienced adults (previous non-darunavir virologic failure [VF] allowed) were randomized (2:1) to D/C/F/TAF or boosted protease inhibitor (PI) plus emtricitabine/tenofovir-disoproxil-fumarate (F/TDF) over 48 weeks. [...]
2019 - 10.1016/j.antiviral.2019.104543
Antiviral Research, Vol. 170 (october 2019) , p. 104543
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
